Brief: Anika Therapeutics Says Q2 Revenue Rose 1 Percent To $30.7 Million

Anika Therapeutics

30/07/2020 22:24

July 30 (Reuters) - Anika Therapeutics Inc  ANIK.O :
    * ANIKA REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS
    * Q2 LOSS PER SHARE $0.54
    * Q2 REVENUE ROSE 1 PERCENT TO $30.7 MILLION
    * Q2 ADJUSTED EARNINGS PER SHARE $0.09
    * LAUNCHING SEVEN FDA-CLEARED ORTHOPEDIC AND SPORTS MEDICINE
PRODUCTS THROUGH Q3 2020

Source text for Eikon:  ID:nGNX3147NX 
Further company coverage:  ANIK.O 

 ((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))